PureTech Health Net Worth
PureTech Health Net Worth Breakdown | PRTC |
PureTech Health Net Worth Analysis
PureTech Health's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including PureTech Health's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of PureTech Health's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform PureTech Health's net worth analysis. One common approach is to calculate PureTech Health's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares PureTech Health's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing PureTech Health's net worth. This approach calculates the present value of PureTech Health's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of PureTech Health's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate PureTech Health's net worth. This involves comparing PureTech Health's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into PureTech Health's net worth relative to its peers.
Enterprise Value |
|
To determine if PureTech Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding PureTech Health's net worth research are outlined below:
| PureTech Health PLC generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 3.33 M. Net Loss for the year was (65.7 M) with loss before overhead, payroll, taxes, and interest of (81.55 M). | |
| PureTech Health PLC currently holds about 368.03 M in cash with (105.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.84. | |
| PureTech Health PLC has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: PureTech to Present at the Leerink Partners Global Healthcare Conference |
PureTech Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in PureTech Health PLC. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to PureTech Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 26th of April 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
PureTech Health Target Price Consensus
PureTech target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. PureTech Health's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 2 | Strong Buy |
Most PureTech analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand PureTech stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of PureTech Health PLC, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationPureTech Health Target Price Projection
PureTech Health's current and average target prices are 16.71 and 53.25, respectively. The current price of PureTech Health is the price at which PureTech Health PLC is currently trading. On the other hand, PureTech Health's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
PureTech Health Market Quote on 21st of March 2025
Target Price
Analyst Consensus On PureTech Health Target Price
Know PureTech Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as PureTech Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading PureTech Health PLC backward and forwards among themselves. PureTech Health's institutional investor refers to the entity that pools money to purchase PureTech Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Birch Hill Investment Advisors Llc | 2024-12-31 | 302 K | Millennium Management Llc | 2024-12-31 | 45.3 K | Pentwater Capital Management Lp | 2024-12-31 | 24.1 K | Ubs Group Ag | 2024-12-31 | 1.9 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 100.0 | Adar1 Capital Management Llc | 2024-12-31 | 0.0 | Tower Research Capital Llc | 2024-09-30 | 0.0 |
Follow PureTech Health's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 428.38 M.Market Cap |
|
Project PureTech Health's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.09) | (0.09) | |
| Return On Capital Employed | (0.26) | (0.25) | |
| Return On Assets | (0.09) | (0.09) | |
| Return On Equity | (0.16) | (0.15) |
When accessing PureTech Health's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures PureTech Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of PureTech Health's profitability and make more informed investment decisions.
Please note, the presentation of PureTech Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, PureTech Health's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of PureTech Health's management manipulating its earnings.
Evaluate PureTech Health's management efficiency
PureTech Health PLC has return on total asset (ROA) of (0.1339) % which means that it has lost $0.1339 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2207) %, meaning that it created substantial loss on money invested by shareholders. PureTech Health's management efficiency ratios could be used to measure how well PureTech Health manages its routine affairs as well as how well it operates its assets and liabilities. As of March 21, 2025, Return On Tangible Assets is expected to decline to -0.09. The current year's Return On Capital Employed is expected to grow to -0.25. The current year's Debt To Assets is expected to grow to 0.07, whereas Total Assets are forecasted to decline to about 544.9 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 14.93 | 15.67 | |
| Tangible Book Value Per Share | 14.90 | 15.64 | |
| Enterprise Value Over EBITDA | (47.44) | (49.81) | |
| Price Book Value Ratio | 0.15 | 0.16 | |
| Enterprise Value Multiple | 6.80 | 7.14 | |
| Price Fair Value | 0.15 | 0.16 | |
| Enterprise Value | 551.6 M | 524 M |
Understanding the operational decisions made by PureTech Health management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Enterprise Value Revenue 348.8244 | Revenue | Quarterly Revenue Growth (0.91) | Revenue Per Share | Return On Equity |
PureTech Health Corporate Filings
| 12th of February 2025 Other Reports | ViewVerify | |
6K | 16th of December 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
13A | 12th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
13A | 7th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
PureTech Health Earnings per Share Projection vs Actual
PureTech Health Corporate Management
| Anita JD | Senior Property | Profile | |
| Lauren MBA | Chief Officer | Profile | |
| David Elmaleh | CoFounder Advisor | Profile | |
| Spencer Ball | Senior Resources | Profile | |
| III JD | General Secretary | Profile | |
| Joseph Bolen | Chief Officer | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PureTech Health PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PureTech Health. If investors know PureTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PureTech Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.615 | Earnings Share (2.92) | Revenue Per Share | Quarterly Revenue Growth (0.91) | Return On Assets |
The market value of PureTech Health PLC is measured differently than its book value, which is the value of PureTech that is recorded on the company's balance sheet. Investors also form their own opinion of PureTech Health's value that differs from its market value or its book value, called intrinsic value, which is PureTech Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PureTech Health's market value can be influenced by many factors that don't directly affect PureTech Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PureTech Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if PureTech Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PureTech Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.